CC BY 4.0 · Surg J (N Y) 2022; 08(01): e8-e13
DOI: 10.1055/s-0041-1741511
Original Article

Short-Term Hip Fracture Outcomes during the COVID-19 Pandemic

1   Department of Trauma & Orthopaedic Surgery, Whipps Cross University Hospital, Barts Health NHS Trust, London, United Kingdom
,
Hassan Raja
1   Department of Trauma & Orthopaedic Surgery, Whipps Cross University Hospital, Barts Health NHS Trust, London, United Kingdom
,
Rachel Ahmad
1   Department of Trauma & Orthopaedic Surgery, Whipps Cross University Hospital, Barts Health NHS Trust, London, United Kingdom
,
Konstantinos Tsitskaris
1   Department of Trauma & Orthopaedic Surgery, Whipps Cross University Hospital, Barts Health NHS Trust, London, United Kingdom
› Author Affiliations
Funding None.

Abstract

Introduction Despite many significant changes as a result of the coronavirus disease 2019 (COVID-19) pandemic, and reductions in overall trauma workload, patients with fragility hip fractures continued to present to hospital. As we plan for ongoing service provision during future waves of the pandemic, valuable lessons can be learned from patients that have been treated surgically during the “first wave.”

Methods All patients admitted to our center (a busy District General Hospital in London, United Kingdom) with a hip fracture during a 13-week period representing the initial rise (“United Kingdom first wave”) in COVID-19 cases, from February 17th to May 17th, 2020 (study group) were compared with hip fracture patients from the equivalent 13-week period in February to May 2019 (control group). The primary outcome was 30-day mortality, and additional information was collected in terms of length of stay (LOS), SARS-CoV-2 antigen testing, and cause of death.

Results During the COVID-19 study period, 69 patients were admitted with a hip fracture, compared with 70 patients in the control group (p = 0.949). There was no significant difference in 30-day mortality between the two groups (5.8 vs. 7.1%, p = 0.747). Mean LOS was shorter in the COVID-19 period compared with the control group (11.6 vs. 19.6 days, p <0.001, effect size 0.572).

Forty-six patients (66.7%) had a SARS-CoV-2 antigen swab test, as testing was not available in the early period, and 10 patients (14.5%) tested positive. None of the patients, who presented before the antigen testing was available, had clinical suspicion of COVID-19 retrospectively. Two “COVID-19 positive” patients (20%) died within 30 days of admission.

Conclusion We report reassuring short-term results demonstrating no statistically significant difference in the 30-day mortality rate of hip fracture patients admitted during the United Kingdom's first wave of the COVID-19 pandemic compared to the equivalent period in the previous year. Hip fracture incidence remained stable, and LOS was reduced, likely due to recent departmental changes as well as a drive to discharge patients quickly during the pandemic. We agree with existing reports that elderly hip fracture patients with COVID-19 have a higher risk of perioperative mortality, however, our results suggest that overall mortality for the whole hip fracture population was similar to the previous year, in which deaths were more commonly attributed to respiratory infections associated with other pathogens. Further work may be needed to evaluate the outcomes during subsequent waves of the pandemic as mutations in the virus and conditions may affect outcomes.



Publication History

Received: 13 January 2021

Accepted: 29 November 2021

Article published online:
17 January 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 GOV.UK. Coronavirus (COVID-19) cases in the UK. 2020; UK statistics for incidence and mortality for coronavirus (COVID-19) cases. Accessed July 3 rd , 2020: https://coronavirus.data.gov.uk/
  • 2 Cronin M, Mullins M, Pathmanaban P. et al. COVID-19 causes a SHiFT in the sands for proximal femoral fracture management? The Transient Journal of Trauma. Accessed April 14, 2020: https://www.boa.ac.uk/resources/covid-19-causes-a-shift-in-the-sands-for-proximal-femoral-fracture-management.html
  • 3 Park C, Sugand K, Nathwani D, Bhattacharya R, Sarraf KM. Impact of the COVID-19 pandemic on orthopedic trauma workload in a London level 1 trauma center: the “golden month”. Acta Orthop 2020; 91 (05) 556-561
  • 4 Nuñez JH, Sallent A, Lakhani K. et al. Impact of the COVID-19 pandemic on an emergency traumatology service: experience at a tertiary trauma centre in Spain. Injury 2020; 51 (07) 1414-1418
  • 5 Kumar Jain V, Lal H, Kumar Patralekh M, Vaishya R. Fracture management during COVID-19 pandemic: a systematic review. J Clin Orthop Trauma 2020; 11 (Suppl. 04) S431-S441
  • 6 Iyengar KP, Jain VK, Vaish A, Vaishya R, Maini L, Lal H. Post COVID-19: planning strategies to resume orthopaedic surgery—challenges and considerations. J Clin Orthop Trauma 2020; 11 (Suppl. 03) S291-S295
  • 7 JASP Team. JASP Version 0.14.1. University of Amsterdam; 2020. Accessed December 29, 2021 at: https://jasp-stats.org
  • 8 The National Hip Fracture Database. NHFD 2019 annual report. Accessed December 29, 2021 at: https://www.nhfd.co.uk/20/hipfractureR.nsf/docs/reports2019
  • 9 Sobti A, Memon K, Bhaskar RRP, Unnithan A, Khaleel A. Outcome of trauma and orthopaedic surgery at a UK District General Hospital during the Covid-19 pandemic. J Clin Orthop Trauma 2020; 11 (Suppl. 04) S442-S445
  • 10 Malik-Tabassum K, Crooks M, Robertson A, To C, Maling L, Selmon G. Management of hip fractures during the COVID-19 pandemic at a high-volume hip fracture unit in the United Kingdom. J Orthop 2020; 20: 332-337
  • 11 Cheung ZB, Forsh DA. Early outcomes after hip fracture surgery in COVID-19 patients in New York City. J Orthop 2020; 21: 291-296
  • 12 Chui K, Thakrar A, Shankar S. Evaluating the efficacy of a two-site (‘COVID-19’ and ‘COVID-19-free’) trauma and orthopaedic service for the management of hip fractures during the COVID-19 pandemic in the UK. Bone Jt Open 2020; 1 (06) 190-197
  • 13 Witek A, Sauvé P. Is the combination of a femur fracture a COVID-19 in the over 65s as bad as we think?. Transient J 2020 Accessed December 29, 2021 at: https://www.boa.ac.uk/resources/knowledge-hub/is-the-combination-of-a-femur-fracture-a-covid-19-in-theover-65s-as-bad-as-we-think.html
  • 14 Muñoz Vives JM, Jornet-Gibert M, Cámara-Cabrera J. et al; Spanish HIP-COVID Investigation Group. Mortality rates of patients with proximal femoral fracture in a worldwide pandemic: preliminary results of the Spanish HIP-COVID observational study. J Bone Joint Surg Am 2020; 102 (13) e69
  • 15 LeBrun DG, Konnaris MA, Ghahramani GC. et al. Hip fracture outcomes during the COVID-19 pandemic: early results from New York. J Orthop Trauma 2020; 34 (08) 403-410
  • 16 Egol KA, Konda SR, Bird ML. et al; NYU COVID Hip Fracture Research Group. Increased mortality and major complications in hip fracture care during the COVID-19 pandemic: a New York City perspective. J Orthop Trauma 2020; 34 (08) 395-402
  • 17 Kayani B, Onochie E, Patil V. et al. The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures. Bone Joint J 2020; 102-B (09) 1136-1145
  • 18 Hall AJ, Clement ND, Farrow L. et al; IMPACT-Scot Study Group. IMPACT-Scot report on COVID-19 and hip fractures. Bone Joint J 2020; 102-B (09) 1219-1228
  • 19 Wang KC, Xiao R, Cheung ZB, Barbera JP, Forsh DA. Early mortality after hip fracture surgery in COVID-19 patients: a systematic review and meta-analysis. J Orthop 2020; 22: 584-591
  • 20 Hewitt J, Carter B, Vilches-Moraga A. et al; COPE Study Collaborators. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health 2020; 5 (08) e444-e451